Study your flashcards anywhere!

Download the official Cram app for free >

  • Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off

How to study your flashcards.

Right/Left arrow keys: Navigate between flashcards.right arrow keyleft arrow key

Up/Down arrow keys: Flip the card between the front and back.down keyup key

H key: Show hint (3rd side).h key

A key: Read text to speech.a key


Play button


Play button




Click to flip

10 Cards in this Set

  • Front
  • Back
- parenteral anticoagulant
- catalyzes inactivation of clotting factors by antithrombin III
- used in low doses post-op
- oral anticoagulant
- delayed action since it prevents synthesis of clotting factors
- antagonizes vitamin K
drug interactions in clotting
- phenylbutazone displaces warfarin from plasma proteins
- barbiturates stimulate metabolic inactivation of anticoagulants
- antibiotics decrease available vitamin K, increasing the effectiveness of anticoagulants
- large vitamin K doses overcome the inhibition
vitamin K
- induces the post-translational carboxylation of factors 2, 7, 9, 10, proteins C and S, prothrombin and maybe tissue factor
class 1 of platelet aggregation inhibitors
- aspirin, indomethacin, sulfinpyrazone inhibit cyclo-oxygenase and block TXA2 formation
- platelet inhibitor which increases intracellular levels of inhibitory messenger cAMP
clopidogrel and ticlopidine
reduce platelet aggregation by inhibiting the ADP pathway of platelet aggregation
abciximab, eptifibatide, tirofiban
glycoprotein IIb/IIIa inhibitors; block the final common pathway for platelet aggregation
streptokinase and urokinase
cause systemic plasmin formation, which degrades numerous circulating proteins like fibrinogen and coagulation factors
t-PA (tissue plasminogen activators)
bind tightly to fibrin and restricts its activity to vicinity of the thrombus